AMGEN INC (AMGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for AMGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AMGN | Director | 72 | ["Executive Vice President for Health Affairs of Duke University since 2023","Dean of the Duke University School of Medicine since 2017","Chief Academic Officer of Duke Health since 2020","Chair of the Department of Medicine at Duke University School of Medicine from 2010 to 2017","Irene and Dr. Arthur M. Fishberg Professor of Medicine at Mount Sinai School of Medicine","Chief of Division of Infectious Diseases at Mount Sinai from 1997 to 2010","Co-director of Mount Sinai’s Global Health and Emerging Pathogens Institute","Director of Inventurus Knowledge Solutions Limited since 2024","Advisory board member of Inventurus Knowledge Solutions Limited since 2022","Elected to the National Academy of Medicine in 2014","Elected to the American Academy of Arts and Sciences in 2021","Received undergraduate degree and medical doctorate from Duke University"] | ["Compensation and Management Development","M","Corporate Responsibility and Compliance","Governance and Nominating","Corporate Responsibility and Compliance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Mary E. Klotman has served as our director since 2024. Dr. Klotman has been Executive Vice President for Health Affairs of Duke University since 2023, Dean of the Duke University School of Medicine since 2017, and Chief Academic Officer of Duke Health since 2020. Dr. Klotman previously served as chair of the Department of Medicine at the Duke University School of Medicine from 2010 to 2017. She was the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Mount Sinai School of Medicine and served as chief of its Division of Infectious Diseases from 1997 to 2010. During this period, Dr. Klotman was also co-director of Mount Sinai s Global Health and Emerging Pathogens Institute, a program designed to translate basic science discoveries into clinical therapeutics for newly emerging and re-emerging infectious diseases. Dr. Klotman has been a director of Inventurus Knowledge Solutions Limited, doing business as IKS Health, a non-U.S. public company, since 2024, for which she has also served on its advisory board since 2022. Dr. Klotman was elected to the National Academy of Medicine in 2014 and the American Academy of Arts and Sciences in 2021. Dr. Klotman received both her undergraduate degree and her medical doctorate from Duke University. Qualifications Our Board concluded that Dr. Klotman should serve on our Board based on her broad medical and scientific background, including her expertise leading an important academic institution, her extensive scientific research, and important contributions as a clinician and physician-scientist.